New perspectives on the involvement of mTOR in depression as well as in the action of antidepressant drugs.
暂无分享,去创建一个
[1] A. Yusuf. mTOR signaling in growth and metabolism , 2017 .
[2] Oliver H. Miller,et al. Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition , 2016, Neuropharmacology.
[3] J. Duan,et al. Involvement of normalized NMDA receptor and mTOR-related signaling in rapid antidepressant effects of Yueju and ketamine on chronically stressed mice , 2015, Scientific Reports.
[4] S. Deutsch,et al. NMDA receptor activation regulates sociability by its effect on mTOR signaling activity , 2015, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[5] M. Jou,et al. AMPA Receptor–mTOR Activation is Required for the Antidepressant-Like Effects of Sarcosine during the Forced Swim Test in Rats: Insertion of AMPA Receptor may Play a Role , 2015, Front. Behav. Neurosci..
[6] Young Hoon Kim,et al. Differential effects of antidepressant drugs on mTOR signalling in rat hippocampal neurons. , 2014, The international journal of neuropsychopharmacology.
[7] E. Delpire,et al. GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine , 2014, eLife.
[8] H. Abelaira,et al. Epigenetic and epistatic interactions between serotonin transporter and brain-derived neurotrophic factor genetic polymorphism: Insights in depression , 2014, Neuroscience.
[9] Zhi-qiang Zhou,et al. Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex , 2014, European Psychiatry.
[10] K. Maiese. Driving neural regeneration through the mammalian target of rapamycin , 2014, Neural regeneration research.
[11] H. Nawa,et al. mTOR signaling and its roles in normal and abnormal brain development , 2014, Front. Mol. Neurosci..
[12] H. Abelaira,et al. The role of mTOR in depression and antidepressant responses. , 2014, Life sciences.
[13] G. Aghajanian,et al. REDD1 is essential for stress-induced synaptic loss and depressive behavior , 2014, Nature Medicine.
[14] J. Long,et al. Monoacylglycerol Lipase Inhibition Blocks Chronic Stress-Induced Depressive-Like Behaviors via Activation of mTOR Signaling , 2014, Neuropsychopharmacology.
[15] Nanxin Li,et al. Scopolamine Rapidly Increases Mammalian Target of Rapamycin Complex 1 Signaling, Synaptogenesis, and Antidepressant Behavioral Responses , 2013, Biological Psychiatry.
[16] Hai-shui Shi,et al. Glycine site N-methyl-D-aspartate receptor antagonist 7-CTKA produces rapid antidepressant-like effects in male rats. , 2013, Journal of psychiatry & neuroscience : JPN.
[17] Dennis S. Charney,et al. Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression , 2013, Biological Psychiatry.
[18] D. Inta,et al. Pharmacological blockade of GluN2B-containing NMDA receptors induces antidepressant-like effects lacking psychotomimetic action and neurotoxicity in the perinatal and adult rodent brain , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[19] Young Hoon Kim,et al. Effect of treadmill exercise on the BDNF-mediated pathway in the hippocampus of stressed rats , 2013, Neuroscience Research.
[20] Jin-Hui Wang,et al. The Stability of NR2B in the Nucleus Accumbens Controls Behavioral and Synaptic Adaptations to Chronic Stress , 2013, Biological Psychiatry.
[21] M. Furey,et al. Antidepressant Effects of the Muscarinic Cholinergic Receptor Antagonist Scopolamine: A Review , 2013, Biological Psychiatry.
[22] R. Duman,et al. Activation of Mammalian Target of Rapamycin and Synaptogenesis: Role in the Actions of Rapid-Acting Antidepressants , 2013, Biological Psychiatry.
[23] Y. Tizabi,et al. Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR , 2013, Psychopharmacology.
[24] G. Aghajanian,et al. GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine , 2013, Neuropsychopharmacology.
[25] H. Abelaira,et al. Imipramine reverses alterations in cytokines and BDNF levels induced by maternal deprivation in adult rats , 2013, Behavioural Brain Research.
[26] H. Abelaira,et al. Effects of lamotrigine on behavior, oxidative parameters and signaling cascades in rats exposed to the chronic mild stress model , 2013, Neuroscience Research.
[27] Zhi-qiang Zhou,et al. Acute administration of ketamine in rats increases hippocampal BDNF and mTOR levels during forced swimming test , 2013, Upsala journal of medical sciences.
[28] M. Austin,et al. Reduced phosphorylation of the mTOR signaling pathway components in the amygdala of rats exposed to chronic stress , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[29] Jean-Marie C. Bouteiller,et al. Roles of group I metabotropic glutamate receptors under physiological conditions and in neurodegeneration , 2012 .
[30] Zhi-qiang Zhou,et al. Tramadol Pretreatment Enhances Ketamine-Induced Antidepressant Effects and Increases Mammalian Target of Rapamycin in Rat Hippocampus and Prefrontal Cortex , 2012, Journal of biomedicine & biotechnology.
[31] D. Sabatini,et al. mTOR Signaling in Growth Control and Disease , 2012, Cell.
[32] Nanxin Li,et al. Signaling pathways underlying the rapid antidepressant actions of ketamine , 2012, Neuropharmacology.
[33] S. Chaki,et al. Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression , 2011, Behavioural Brain Research.
[34] M. Austin,et al. The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[35] E. Kavalali,et al. NMDA Receptor Blockade at Rest Triggers Rapid Behavioural Antidepressant Responses , 2011, Nature.
[36] A. Mallinger,et al. Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[37] A. Pillai,et al. Long-Term Continuous Corticosterone Treatment Decreases VEGF Receptor-2 Expression in Frontal Cortex , 2011, PloS one.
[38] R. Jope,et al. Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice , 2011, Molecular Psychiatry.
[39] Nanxin Li,et al. Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure , 2011, Biological Psychiatry.
[40] Mesut Çetin,et al. Beyond the glutamate N-methyl D-aspartate receptor in major depressive disorder: the mTOR signaling pathway / Majör depresif bozuklukta glutamat N-metil-D-aspartat reseptörlerinin ötesi: mTOR sinyal yolağı , 2011 .
[41] Brian K. Kennedy,et al. TOR on the brain , 2011, Experimental Gerontology.
[42] D. Sabatini,et al. mTOR: from growth signal integration to cancer, diabetes and ageing , 2010, Nature Reviews Molecular Cell Biology.
[43] Ronald S Duman,et al. Peripheral BDNF Produces Antidepressant-Like Effects in Cellular and Behavioral Models , 2011, Neuropsychopharmacology.
[44] I. Lucki,et al. Fluoxetine treatment induces dose dependent alterations in depression associated behavior and neural plasticity in female mice , 2010, Neuroscience Letters.
[45] S. Horvath,et al. Biomarkers to Predict Antidepressant Response , 2010, Current psychiatry reports.
[46] Nanxin Li,et al. mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists , 2010, Science.
[47] D. Luckenbaugh,et al. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. , 2010, Archives of general psychiatry.
[48] M. Furey,et al. Replication of Scopolamine's Antidepressant Efficacy in Major Depressive Disorder: A Randomized, Placebo-Controlled Clinical Trial , 2010, Biological Psychiatry.
[49] E. Klann,et al. mTOR signaling: At the crossroads of plasticity, memory and disease , 2010, Trends in Neurosciences.
[50] J. R. Gomes,et al. BDNF-induced changes in the expression of the translation machinery in hippocampal neurons: protein levels and dendritic mRNA. , 2009, Journal of proteome research.
[51] M. Kawamura,et al. Brain-derived Neurotrophic Factor Enhances the Basal Rate of Protein Synthesis by Increasing Active Eukaryotic Elongation Factor 2 Levels and Promoting Translation Elongation in Cortical Neurons* , 2009, The Journal of Biological Chemistry.
[52] M. Krams,et al. An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder , 2008, Journal of clinical psychopharmacology.
[53] A. Zangen,et al. Age‐dependent effects of chronic stress on brain plasticity and depressive behavior , 2008, Journal of neurochemistry.
[54] H. Schmidt,et al. Future Antidepressant Targets: Neurotrophic Factors and Related Signaling Cascades. , 2008, Drug discovery today. Therapeutic strategies.
[55] H. Manji,et al. The Role of AMPA receptor modulation in the treatment of neuropsychiatric diseases , 2008, Experimental Neurology.
[56] Carlos A. Zarate,et al. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders , 2008, Nature Reviews Drug Discovery.
[57] June-Seek Choi,et al. Vascular endothelial growth factor (VEGF) signaling regulates hippocampal neurons by elevation of intracellular calcium and activation of calcium/calmodulin protein kinase II and mammalian target of rapamycin. , 2008, Cellular signalling.
[58] Guang Chen,et al. Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors , 2008, Biological Psychiatry.
[59] B. Moghaddam,et al. NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons , 2007, The Journal of Neuroscience.
[60] H. Manji,et al. The Anticonvulsants Lamotrigine, Riluzole, and Valproate Differentially Regulate AMPA Receptor Membrane Localization: Relationship to Clinical Effects in Mood Disorders , 2007, Neuropsychopharmacology.
[61] R. Duman,et al. VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants , 2007, Proceedings of the National Academy of Sciences.
[62] A. Serretti,et al. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients , 2007, Molecular Psychiatry.
[63] G. Collingridge,et al. LTP Inhibits LTD in the Hippocampus via Regulation of GSK3β , 2007, Neuron.
[64] S. Snyder,et al. The Cationic Amino Acid Transporters CAT1 and CAT3 Mediate NMDA Receptor Activation-Dependent Changes in Elaboration of Neuronal Processes via the Mammalian Target of Rapamycin mTOR Pathway , 2007, The Journal of Neuroscience.
[65] A. Malafosse,et al. Alteration in Kinase Activity But Not in Protein Levels of Protein Kinase B and Glycogen Synthase Kinase-3β in Ventral Prefrontal Cortex of Depressed Suicide Victims , 2007, Biological Psychiatry.
[66] Debabrata Panja,et al. Dual regulation of translation initiation and peptide chain elongation during BDNF‐induced LTP in vivo: evidence for compartment‐specific translation control , 2006, Journal of neurochemistry.
[67] C. Siao,et al. Genetic Variant BDNF (Val66Met) Polymorphism Alters Anxiety-Related Behavior , 2006, Science.
[68] W. Sossin,et al. Serotonin Increases Phosphorylation of Synaptic 4EBP through TOR, but Eukaryotic Initiation Factor 4E Levels Do Not Limit Somatic Cap-Dependent Translation in Aplysia Neurons , 2006, Molecular and Cellular Biology.
[69] Ming You,et al. TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth , 2006, Cell.
[70] L. Barrier,et al. Group I metabotropic glutamate receptors activate the p70S6 kinase via both mammalian target of rapamycin (mTOR) and extracellular signal-regulated kinase (ERK 1/2) signaling pathways in rat striatal and hippocampal synaptoneurosomes , 2006, Neurochemistry International.
[71] Paul J Carlson,et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. , 2006, Archives of general psychiatry.
[72] R. Duman,et al. A Neurotrophic Model for Stress-Related Mood Disorders , 2006, Biological Psychiatry.
[73] C. Bramham,et al. Chronic fluoxetine induces region‐specific changes in translation factor eIF4E and eEF2 activity in the rat brain , 2006, The European journal of neuroscience.
[74] B. Lebowitz,et al. Medication augmentation after the failure of SSRIs for depression. , 2006, The New England journal of medicine.
[75] M. Hall,et al. TOR Signaling in Growth and Metabolism , 2006, Cell.
[76] M. Furey,et al. Antidepressant Efficacy of the Antimuscarinic Drug Scopolamine , 2006 .
[77] C. Hoogenraad,et al. Control of Dendritic Arborization by the Phosphoinositide-3′-Kinase–Akt–Mammalian Target of Rapamycin Pathway , 2005, The Journal of Neuroscience.
[78] Gang-yi Wu,et al. Regulation of Dendritic Morphogenesis by Ras–PI3K–Akt–mTOR and Ras–MAPK Signaling Pathways , 2005, The Journal of Neuroscience.
[79] N. Sonenberg,et al. The Translation Repressor 4E-BP2 Is Critical for eIF4F Complex Formation, Synaptic Plasticity, and Memory in the Hippocampus , 2005, The Journal of Neuroscience.
[80] Kenta Hara,et al. Brain-Derived Neurotrophic Factor Induces Mammalian Target of Rapamycin-Dependent Local Activation of Translation Machinery and Protein Synthesis in Neuronal Dendrites , 2004, The Journal of Neuroscience.
[81] A. Schatzberg,et al. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression. , 2004, Archives of general psychiatry.
[82] W. Sossin,et al. 5‐HT stimulates eEF2 dephosphorylation in a rapamycin‐sensitive manner in Aplysia neurites , 2004, Journal of neurochemistry.
[83] J Ormel,et al. Functional disability and depression in the general population. Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS) , 2004, Acta psychiatrica Scandinavica.
[84] M. Barrot,et al. Essential role of brain-derived neurotrophic factor in adult hippocampal function. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[85] J. Blenis,et al. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression , 2004, Oncogene.
[86] Christopher G. Proud,et al. A Novel mTOR-Regulated Phosphorylation Site in Elongation Factor 2 Kinase Modulates the Activity of the Kinase and Its Binding to Calmodulin , 2004, Molecular and Cellular Biology.
[87] J. Medina,et al. ERK1/2 activation is necessary for BDNF to increase dendritic spine density in hippocampal CA1 pyramidal neurons. , 2004, Learning & memory.
[88] Olga V. Demler,et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). , 2003, JAMA.
[89] A. Nairn,et al. Adenylyl cyclase-dependent form of chemical long-term potentiation triggers translational regulation at the elongation step , 2003, Neuroscience.
[90] E. Castrén,et al. Activation of the TrkB Neurotrophin Receptor Is Induced by Antidepressant Drugs and Is Required for Antidepressant-Induced Behavioral Effects , 2003, The Journal of Neuroscience.
[91] M. Cuesta,et al. [Neurobiology of depression]. , 2002, Anales del sistema sanitario de Navarra.
[92] R. Duman,et al. Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression , 2002, The Journal of Neuroscience.
[93] Mark Farrant,et al. NMDA receptor subunits: diversity, development and disease , 2001, Current Opinion in Neurobiology.
[94] Jeffrey A Lieberman,et al. Effects of Ketamine, MK-801, and Amphetamine on Regional Brain 2-Deoxyglucose Uptake in Freely Moving Mice , 2000, Neuropsychopharmacology.
[95] John H Krystal,et al. Antidepressant effects of ketamine in depressed patients , 2000, Biological Psychiatry.
[96] A. Gingras,et al. μ-Opioid Receptor Activates Signaling Pathways Implicated in Cell Survival and Translational Control* , 1998, The Journal of Biological Chemistry.
[97] J. Heitman,et al. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast , 1991, Science.